Si Lu
Si Lu — Chief Physician — Melanoma & Sarcoma — Peking University Cancer Hospital
Specialties
Engaged in the clinical diagnosis and treatment of melanoma, sarcoma, renal cancer, and urothelial carcinoma for more than 20 years, focusing on innovative drug development and clinical translation in oncology, promoting the market launch of 7 new anti-tumor drugs, and formulating 13 innovative treatment protocols.
Education
Doctor of Medicine
Professional Experience
Associate Chief Physician of the Department of Melanoma and Sarcoma, Chief Physician, Professor, and PhD Supervisor. He has been engaged in the clinical diagnosis and treatment of melanoma, sarcoma, renal cancer, and urothelial carcinoma for more than 20 years, focusing on the research and clinical translation of innovative tumor drugs, promoting the market launch of 7 new anti-tumor drugs, and formulating 13 innovative treatment plans.
Professional Roles
Currently serving as the Academic Secretary of the Asian Melanoma Alliance, Deputy Director of the Melanoma Expert Committee of the Chinese Society of Clinical Oncology, Deputy Director of the Neuro-Oncology Committee of CSCO, member of the Brain Metastasis Committee of the Beijing Medical Award Foundation, standing member of the Rare Tumor Committee of CSCO, and member of the Immunotherapy Committee of CSCO.